scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203309356455 |
P8608 | Fatcat ID | release_t7wtczczebd75hdoaoujaxr4lq |
P698 | PubMed publication ID | 20064914 |
P50 | author | Anna Sysa-Jedrzejowska | Q47087815 |
P2093 | author name string | D P McCauliffe | |
J Narbutt | |||
A Lesiak | |||
J Lukamowicz | |||
A Wózniacka | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
chloroquine | Q422438 | ||
chloroquine phosphate | Q27264629 | ||
P304 | page(s) | 683-688 | |
P577 | publication date | 2010-01-11 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus | |
P478 | volume | 19 |
Q90594140 | Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes |
Q52567976 | Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis. |
Q26996498 | Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus |
Q92511809 | Association between Serum Matrix Metalloproteinase- (MMP-) 3 Levels and Systemic Lupus Erythematosus: A Meta-analysis |
Q30513775 | Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy |
Q39155625 | Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo |
Q39044818 | Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function |
Q38182192 | Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? |
Q53609113 | Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. |
Q38285841 | Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases |
Q37827403 | Hydroxychloroquine: from malaria to autoimmunity |
Q37991390 | Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents |
Q28548561 | Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease |
Q38557048 | Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics |
Q41911830 | Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy |
Q34084599 | Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2 |
Q38026787 | New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. |
Q36047368 | Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model |
Q38985926 | Strategies to limit immune-activation in HIV patients. |
Q39432359 | Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells |
Q38026775 | The beneficial role of vitamin D in systemic lupus erythematosus (SLE). |
Q37947108 | The role of antimalarial agents in the treatment of SLE and lupus nephritis |
Q39112090 | Treatment of preeclampsia with hydroxychloroquine: a review |
Search more.